China PharmaHub Acquires mAb Platform; Aims toward Reverse Merger

China PharmaHub Corp. has set up a joint venture with two researchers that will own intellectual property for humanizing antibodies. At the same time, China PharmaHub said it is pursuing a transaction to complete a reverse merger that will list the company on the OTC Bulletin Board. More details...